Geographical variation in therapy for bloodstream infections due to multidrug-resistant Enterobacteriaceae: a post-hoc analysis of the INCREMENT study

Autor: Harris, PNA, Pezzani, MD, Gutierrez-Gutierrez, B, Viale, P, Hsueh, PR, Ruiz-Garbajosa, P, Venditti, M, Tumbarello, M, Navarro-Francisco, C, Calbo, E, Akova, M, Giamarellou, H, Oliver, A, Almirante, B, Gasch, O, Martinez-Martinez, L, Schwaber, MJ, Daikos, G, Pitout, J, Pena, C, Hernandez-Torres, A, Doi, Y, Perez, F, Tuon, FF, Tacconelli, E, Carmeli, Y, Bonomo, RA, Pascual, A, Paterson, DL, Rodriguez-Bano, J, Prim N., Navarro F., Mirelis B., Jové, E.

Publikováno v: INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname

We describe regional differences in therapy for bloodstream infection (BSI) caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-E) or carbapenemase-producing Enterobacteriaceae (CPE). Patients (n = 1482) in 12 countries from

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::3c77939b9fc6cc688d4bc1164bd9db4a
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=6210

Expert consensus on antimicrobial resistance research priorities to focus development and implementation of antibacterial vaccines and monoclonal antibodies.

Autor: Hassoun-Kheir N; Infection Control Program, Geneva University Hospitals and Faculty of Medicine, WHO Collaborating Center, Geneva, Switzerland., Guedes M; Infection and Antimicrobial Resistance Control and Prevention Unit, Hospital Epidemiology Centre, Centro Hospitalar Universitário São João, Porto, Portugal.; Instituto de Biomedicina de Sevilla (IBiS), Infectious Diseases and Microbiology Division, Hospital Universitario Virgen Macarena, Department of Medicine, University of Sevilla/CSIC, Sevilla, Spain., Arieti F; Infectious Diseases, Department of Diagnostics and Public Health, University of Verona, Verona, Italy., Pezzani MD; Infectious Diseases, Department of Diagnostics and Public Health, University of Verona, Verona, Italy., Gladstone BP; DZIF-Clinical Research Unit, Infectious Diseases, Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany., Robotham JV; HCAI, Fungal, AMR, AMU & Sepsis Division, UK Health Security Agency, London, United Kingdom., Pouwels KB; Health Economics Research Centre, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom., Kingston R; HCAI, Fungal, AMR, AMU & Sepsis Division, UK Health Security Agency, London, United Kingdom., Carmeli Y; National Institute for Antibiotic Resistance and Infection Control, Ministry of Health, Tel Aviv; Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Cassini A; Infectious Diseases Service, Lausanne University Hospital, Lausanne, Switzerland and Public Health Department, Canton of Vaud, Lausanne, Switzerland., Cecchini M; Head of Public Health, Health Division, OECD (Organisation for Economic Co-operation and Development), Paris, France., Drobniewski F; Department of Infectious Disease, Imperial College London, London, United Kingdom., Frost I; AstraZeneca, Eastbrook House, Cambridge, United Kingdom., Geurtsen J; Bacterial Vaccines Research & Early Development, Janssen Vaccines & Prevention B.V., Leiden, the Netherlands., Kronenberg A; Swiss Centre for Antibiotic Resistance, Institute for Infectious Diseases, University of Bern, Bern, Switzerland., Htay MNN; Department of Community Medicine, Faculty of Medicine, Manipal University College Malaysia, Melaka, Malaysia., Paul M; Infectious Diseases Institute, Rambam Health Care Campus; Faculty of Medicine, Technion - Israel Institute of Technology, Haifa, Israel., Rocha-Pereira N; Department of Medicine, Faculdade de Medicina da Universidade do Porto, Porto, Portugal.; Infection and Antimicrobial Resistance Control and Prevention Unit, Hospital Epidemiology Centre, Centro Hospitalar Universitário São João, Porto, Portugal., Rodríguez-Baño J; CIBERINFEC, Instituto de Salud Carlos III, Madrid, Spain.; Instituto de Biomedicina de Sevilla (IBiS), Infectious Diseases and Microbiology Division, Hospital Universitario Virgen Macarena, Department of Medicine, University of Sevilla/CSIC, Sevilla, Spain., Scudeller L; Research and Innovation Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy., Stewardson AJ; Department of Infectious Diseases, The Alfred Hospital and School of Translational Medicine, Monash University, Melbourne, Victoria, Australia., Tacconelli E; Infectious Diseases, Department of Diagnostics and Public Health, University of Verona, Verona, Italy., Harbarth S; Infection Control Program, Geneva University Hospitals and Faculty of Medicine, WHO Collaborating Center, Geneva, Switzerland., Vella V; GSK, Siena, Italy., de Kraker ME; Infection Control Program, Geneva University Hospitals and Faculty of Medicine, WHO Collaborating Center, Geneva, Switzerland.

Publikováno v: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin [Euro Surveill] 2024 Nov; Vol. 29 (47).

A systematic review on the excess health risk of antibiotic-resistant bloodstream infections for six key pathogens in Europe.

Autor: Hassoun-Kheir N; Infection Control Program, Geneva University Hospitals and Faculty of Medicine, World Health Organization Collaborating Center, Geneva, Switzerland., Guedes M; Department of Medicine, University of Sevilla/Instituto de Biomedicina de Sevilla (IBiS)/Consejo Superior de Investigaciones Científicas (CSIC), Sevilla, Spain; Infectious Diseases and Microbiology Division, Hospital Universitario Virgen Macarena, Sevilla, Spain; Infection and Antimicrobial Resistance Control and Prevention Unit, Hospital Epidemiology Centre, Centro Hospitalar Universitário São João, Porto, Portugal., Ngo Nsoga MT; Infection Control Program, Geneva University Hospitals and Faculty of Medicine, World Health Organization Collaborating Center, Geneva, Switzerland., Argante L; Department of Vaccine Clinical Statistics, GSK, Siena, Italy., Arieti F; Infectious Diseases, Department of Diagnostics and Public Health, University of Verona, Verona, Italy., Gladstone BP; The German Center for Infection Research (DZIF)-Clinical Research Unit, Infectious Diseases, Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany., Kingston R; Healthcare Associated Infection, Fungal, Antimicrobial Resistance, Antimicrobial Usage & Sepsis Division, United Kingdon Health Security Agency, London, UK., Naylor NR; Healthcare Associated Infection, Fungal, Antimicrobial Resistance, Antimicrobial Usage & Sepsis Division, United Kingdon Health Security Agency, London, UK., Pezzani MD; Infectious Diseases, Department of Diagnostics and Public Health, University of Verona, Verona, Italy., Pouwels KB; Health Economics Research Centre, Nuffield Department of Population Health, University of Oxford, Oxford, UK., Robotham JV; Healthcare Associated Infection, Fungal, Antimicrobial Resistance, Antimicrobial Usage & Sepsis Division, United Kingdon Health Security Agency, London, UK., Rodríguez-Baño J; Department of Medicine, University of Sevilla/Instituto de Biomedicina de Sevilla (IBiS)/Consejo Superior de Investigaciones Científicas (CSIC), Sevilla, Spain; Infectious Diseases and Microbiology Division, Hospital Universitario Virgen Macarena, Sevilla, Spain; CIBERINFEC, Instituto de Salud Carlos III, Madrid, Spain., Tacconelli E; Infectious Diseases, Department of Diagnostics and Public Health, University of Verona, Verona, Italy., Vella V; Department of Bacterial Vaccine Epidemiology, GSK, Siena, Italy., Harbarth S; Infection Control Program, Geneva University Hospitals and Faculty of Medicine, World Health Organization Collaborating Center, Geneva, Switzerland., de Kraker MEA; Infection Control Program, Geneva University Hospitals and Faculty of Medicine, World Health Organization Collaborating Center, Geneva, Switzerland. Electronic address: marlieke.dekraker@hcuge.ch.

Publikováno v: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases [Clin Microbiol Infect] 2024 Mar; Vol. 30 Suppl 1, pp. S14-S25. Date of Electronic Publication: 2023 Oct 04.

Author Correction: Modelling antimicrobial resistance transmission to guide personalized antimicrobial stewardship interventions and infection control policies in healthcare setting: a pilot study.

Autor: Durazzi F; Department of Physics and Astronomy, University of Bologna, Bologna, Italy., Pezzani MD; Division of Infectious Diseases, Department of Diagnostics and Public Health, University of Verona, Verona, Italy., Arieti F; Division of Infectious Diseases, Department of Diagnostics and Public Health, University of Verona, Verona, Italy., Simonetti O; Infectious Diseases Unit, University Hospital, Trieste, Italy., Canziani LM; Division of Infectious Diseases, Department of Diagnostics and Public Health, University of Verona, Verona, Italy., Carrara E; Division of Infectious Diseases, Department of Diagnostics and Public Health, University of Verona, Verona, Italy., Barbato L; Department of Pharmacy, Azienda Ospedaliera Universitaria Integrata Verona, Verona, Italy., Onorati F; Department of Cardiac Surgery, Verona University Hospital, Verona, Italy., Remondini D; Department of Physics and Astronomy, University of Bologna, Bologna, Italy. daniel.remondini@unibo.it., Tacconelli E; Division of Infectious Diseases, Department of Diagnostics and Public Health, University of Verona, Verona, Italy.

Publikováno v: Scientific reports [Sci Rep] 2024 Jan 09; Vol. 14 (1), pp. 866. Date of Electronic Publication: 2024 Jan 09.

EPI-Net One Health reporting guideline for antimicrobial consumption and resistance surveillance data: a Delphi approach.

Autor: Babu Rajendran N; Infectious Diseases, Department of Internal Medicine I, University Hospital Tübingen, Tübingen, Germany., Arieti F; Infectious Diseases Section, Department of Diagnostics and Public Health, University of Verona, Verona, Italy., Mena-Benítez CA; Infectious Diseases Section, Department of Diagnostics and Public Health, University of Verona, Verona, Italy., Galia L; Infectious Diseases Section, Department of Diagnostics and Public Health, University of Verona, Verona, Italy., Tebon M; Infectious Diseases Section, Department of Diagnostics and Public Health, University of Verona, Verona, Italy., Alvarez J; VISAVET Health Surveillance Center and Department of Animal Health, Faculty of Veterinary Medicine, Complutense University, Madrid, Spain., Gladstone BP; Infectious Diseases, Department of Internal Medicine I, University Hospital Tübingen, Tübingen, Germany.; German Centre for Infection Research (DZIF) Clinical Research Unit for Healthcare Associated and Antibiotic Resistant Bacterial Infections, Tübingen, Germany., Collineau L; French Agency for Food, Environmental and Occupational Health and Safety, ANSES, Maisons-Alfort, France., De Angelis G; Dipartimento di Scienze Biotecnologiche di base, Cliniche Intensivologiche e Perioperatorie, Universita Cattolica del Sacro Cuore, Rome, Italy., Duro R; Unit for the Prevention and Control of Infection and Antimicrobial Resistance, Centro Hospitalar do Tâmega e Sousa, Penafiel, Porto, Portugal., Gaze W; The European Centre for Environment and Human Health, University of Exeter Medical School, University of Exeter, Penryn, Cornwall, UK., Göpel S; Infectious Diseases, Department of Internal Medicine I, University Hospital Tübingen, Tübingen, Germany.; German Centre for Infection Research (DZIF) Clinical Research Unit for Healthcare Associated and Antibiotic Resistant Bacterial Infections, Tübingen, Germany., Kanj SS; Department of Internal Medicine, Division of Infectious Diseases, Infection Control Program, Antimicrobial Stewardship Program, American University of Beirut Medical Center, Beirut, Lebanon., Käsbohrer A; German Federal Institute for Risk Assessment (BfR), Department 4 - Biological Safety, Berlin, Germany., Limmathurotsakul D; Mahidol Oxford Tropical Medicine Research Unit and Department of Tropical Hygiene, Faculty of Tropical Medicine, Mahidol University, Thailand.; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, UK., Lopez de Abechuco E; German Federal Institute for Risk Assessment (BfR), Department 4 - Biological Safety, Berlin, Germany., Mazzolini E; Department of Epidemiology, Istituto Zooprofilattico Sperimentale delle Venezie, Udine-Padova, Padua, Italy., Mutters NT; Institute for Hygiene and Public Health, Bonn University Hospital, Bonn, Germany.; European Committee on Infection Control, Basel, Switzerland., Pezzani MD; Infectious Diseases Section, Department of Diagnostics and Public Health, University of Verona, Verona, Italy., Presterl E; European Committee on Infection Control, Basel, Switzerland.; Department of Infection Control and Hospital Epidemiology, Medical University of Vienna, Vienna, Austria.; ESCMID Study Group for Nosocomial Infections, Basel, Switzerland., Renk H; Department of Paediatric Cardiology, Pulmology and Intensive Care Medicine, University Children's Hospital Tübingen, Tübingen, Germany., Rodríguez-Baño J; Infectious Diseases and Microbiology Division, Hospital Universitario Virgen Macarena/Department of Medicine, School of Medicine, University of Seville/Biomedicine Institute of Seville (IBiS)/CSIC, Seville, Spain.; CIBERINFEC, Instituto de Salud Carlos III, Madrid, Spain., Săndulescu O; Department of Infectious Diseases I, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.; National Institute for Infectious Diseases 'Prof. Dr. Matei Balș', Bucharest, Romania., Scali F; Istituto Zooprofilattico Sperimentale della Lombardia e Dell'Emilia Romagna, Brescia, Italy., Skov R; Epidemiological Infectious Disease Preparedness, Statens Serum Institut, Copenhagen, Denmark., Velavan TP; Institute of Tropical Medicine, Universitätsklinikum Tübingen, Tübingen, Germany.; Vietnamese - German Center for Medical Research, Hanoi, Vietnam., Vuong C; AiCuris Anti-infective Cures GmbH, Wuppertal, Germany.; Jansen Pharmaceuticals, Beerse, Belgium., Tacconelli E; Infectious Diseases Section, Department of Diagnostics and Public Health, University of Verona, Verona, Italy.; European Committee on Infection Control, Basel, Switzerland.

Publikováno v: The Lancet regional health. Europe [Lancet Reg Health Eur] 2022 Dec 22; Vol. 26, pp. 100563. Date of Electronic Publication: 2022 Dec 22 (Print Publication: 2023).